4.5 Review

Increasing incidence rate of breast cancer in cystic fibrosis-relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinical outcome and prognosis of cystic fibrosis due to estrogens

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Malignancies in patients with cystic fibrosis: a case series

Dorothea Appelt et al.

Summary: Through retrospective identification of malignant diseases in patients with cystic fibrosis, it was found that most cancer diagnoses occurred in patients under 30 years old, and half of the patients died from the malignant disease. The incidence rate in female patients was significantly higher than in male patients.

JOURNAL OF MEDICAL CASE REPORTS (2022)

Article Respiratory System

Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study

Olga Archangelidi et al.

Summary: This study investigated the incidence of cancer and associated risk factors in the UK cystic fibrosis population. The results showed that approximately 1.1% of registered patients had malignancies, with a portion occurring after solid organ transplant. The study found that cystic fibrosis-related diabetes and proton pump inhibitor use were associated with cancer incidence.

JOURNAL OF CYSTIC FIBROSIS (2022)

Article Oncology

Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank

Zhuqing Shi et al.

Summary: The study found significant associations between CFTR F508del carriers and colorectal cancer, cancers of gallbladder and biliary tract, thyroid cancer, and unspecified non-Hodgkin's lymphoma. On the other hand, the carrier rate was significantly lower in lung and bronchus cancer patients. Further research is needed to confirm the potential biological and clinical implications of these associations.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Respiratory System

Breast development in a 7 year old girl with CF treated with ivacaftor: An indication for personalized dosing?

Joshena Jeyaratnam et al.

Summary: The introduction of CFTR modulators has led to significant progress in the treatment of Cystic fibrosis, but the long-term side effects of these drugs are poorly understood. A study found that treatment with ivacaftor can cause rare dose-dependent side effects like breast development, and investigated the correlation between drug plasma concentration and clinical effect in patients.

JOURNAL OF CYSTIC FIBROSIS (2021)

Review Respiratory System

Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes

Grace Y. Lam et al.

Summary: This review focuses on the impact of female sex hormones on CF pulmonary outcomes, summarizing data from in vitro and in vivo experiments on how estrogen and progesterone may modify mucociliary clearance, immunity, and infection in the CF airways. The potential for novel sex hormone-related therapeutic interventions is also discussed.

ERJ OPEN RESEARCH (2021)

Review Oncology

Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer

Maria Florencia Mercogliano et al.

FRONTIERS IN ONCOLOGY (2020)

Review Chemistry, Medicinal

Estrogen signaling: An emanating therapeutic target for breast cancer treatment

Tanmay Saha et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Respiratory System

Female reproductive health in cystic fibrosis

Kara S. Hughan et al.

JOURNAL OF CYSTIC FIBROSIS (2019)

Article Biochemistry & Molecular Biology

Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer

Jie Ting Zhang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)

Article Oncology

Cancer Risk in Cystic Fibrosis: A 20-Year Nationwide Study From the United States

Patrick Maisonneuve et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)

Article Critical Care Medicine

17β-Estradiol Inhibits IL-8 in Cystic Fibrosis by Up-Regulating Secretory Leucoprotease Inhibitor

Sanjay H. Chotirmall et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Article Oncology

Cancer risk among patients with cystic fibrosis and their first-degree relatives

Marie Johannesson et al.

INTERNATIONAL JOURNAL OF CANCER (2009)

Article Obstetrics & Gynecology

Morphologic effects of epithelial ion channels on the mouse uterus: differences between raloxifene analog (LY117018) and estradiol treatments

Takahiro Nobuzane et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)

Review Chemistry, Medicinal

Estrogen and Its Receptors in Cancer

George G. Chen et al.

MEDICINAL RESEARCH REVIEWS (2008)

Article Cell Biology

Altered biogenesis of Delta F508-CFTR following treatment with doxorubicin

Rangan Maitra et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2007)

Article Physiology

TGF-beta 1 downregulates CFTR expression and function in nasal polyps of non-CF patients

V Pruliere-Escabasse et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)

Article Cardiac & Cardiovascular Systems

Low-dose methotrexate for advanced pulmonary disease in patients with cystic fibrosis

M Ballmann et al.

RESPIRATORY MEDICINE (2003)